Keyphrases
PARP Inhibitor (PARPi)
100%
Peripheral Neuropathy
100%
Diabetic Mouse Model
100%
PJ34
100%
Streptozotocin-induced Diabetic Rats
100%
Orally Active
100%
Diabetic Rats
62%
Nerve
25%
Poly(ADP-ribose)
25%
Phosphocreatine
25%
High Phosphate
25%
Diabetic Neuropathy
25%
Nicotinamide Adenine Dinucleotide (NAD+)
25%
Nerve Blood Flow
25%
Motor Nerve Conduction Velocity
25%
Sensory Nerve Conduction Velocity
25%
Immunohistochemistry
12%
Gene Expression
12%
Blood Flow
12%
Protein Kinase
12%
Diabetic
12%
Therapeutic Agents
12%
Immunostaining
12%
Poly(ADP-ribose) Polymerase
12%
Direct Action
12%
Sciatic Nerve
12%
Blood Glucose
12%
Sorbitol
12%
Fructose
12%
Glutamate Dehydrogenase
12%
Functional Abnormalities
12%
Lactate Dehydrogenase
12%
Vascular Conductance
12%
Schwann Cells
12%
Metabolic Abnormalities
12%
Inhibitor Treatment
12%
Hydrogen Clearance
12%
Wistar Rat Model
12%
Spectrofluorimetric Method
12%
Energy State
12%
Neuroscience
Diabetes Mellitus
100%
Streptozotocin
100%
PARP Inhibitor
100%
Neuropathy
100%
Immunohistochemistry
40%
Poly(adenosine Diphosphate Ribose)
40%
High Energy Phosphate
40%
Creatine Phosphate
40%
Diabetic Neuropathy
40%
Motor Nerve Conduction
40%
Sensory Nerve Conduction
40%
Gene Expression
20%
Poly ADP Ribose Polymerase
20%
Sciatic Nerve
20%
Protein Kinase C
20%
Lactate Dehydrogenase
20%
Schwann Cell
20%
Sorbitol
20%
Glutamate Dehydrogenase
20%
Fructose
20%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
100%
Rat Model
100%
Streptozotocin
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
100%
Neuropathy
100%
N (5,6 Dihydro 6 Oxo 2 Phenanthridinyl) 2 Dimethylaminoacetamide
100%
Poly(adenosine Diphosphate Ribose)
25%
Diabetic Neuropathy
25%
Creatine Phosphate
25%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
12%
Protein Kinase C
12%
Wistar Rat
12%
Fructose
12%
Glutamate Dehydrogenase
12%
Lactate Dehydrogenase
12%
Sorbitol
12%